Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-α- and -β-cyclodextrins

被引:23
作者
Kimura, K [1 ]
Hirayama, F [1 ]
Arima, H [1 ]
Uekama, K [1 ]
机构
[1] Kumamoto Univ, Fac Pharmaceut Sci, Kumamoto 8620973, Japan
关键词
tolbutamide; 2-hydroxypropyl cyclodextrins; inclusion complex; amorphous solid; solid-state C-13 NMR spectroscopy;
D O I
10.1023/A:1018958116349
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The objective of the study was to obtain structural information of inclusion complexes of tolbutamide with HP-alpha- and -beta-cyclodextrins in amorphous state. Method. The solid complexes of tolbutamide with HP-alpha- and -beta-CyDs in molar ratios of 1:1 and 1:2 (guest:host) were prepared by the spray-drying method, and their interactions were investigated by solid-state C-13 nuclear magnetic resonance (NMR) spectroscopy. Results. The solid 1:1 and 1:2 tolbutamide/HP-CyD complexes showed halo pattern on the powder X-ray diffractogram and no thermal change in DSC curves, indicating they are in an amorphous state. C-13 NMR signals of the butyl moiety were broader than those of the phenyl moiety in the HP-alpha-CyD solid complex, whereas the phenyl moiety showed significantly broader signals than the butyl moiety in the HP-beta-CyD solid complex. As temperature increased, signals of the phenyl carbons became markedly sharper, whereas the butyl carbons only sharpen slightly in the HP-d-CyD complex. In contrast, signals of the butyl carbons became significantly sharper whereas those of phenyl carbons only slightly changed in the HP-beta-CyD complex. Conclusions. Solid state C-13 NMR spectroscopic studies indicated that the butyl moiety of tolbutamide is predominantly included in the HP-alpha-CyD cavity, whereas the phenyl moiety in the HP-beta-CyD cavity in amorphous complexes.
引用
收藏
页码:1729 / 1734
页数:6
相关论文
共 28 条
[1]  
Bender M.L., 1978, Cyclodextrin Chemistry
[2]  
Bisson AP, 1998, CHEM-EUR J, V4, P845, DOI 10.1002/(SICI)1521-3765(19980515)4:5<845::AID-CHEM845>3.0.CO
[3]  
2-#
[4]   SOLID-STATE NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY - THEORY AND PHARMACEUTICAL APPLICATIONS [J].
BUGAY, DE .
PHARMACEUTICAL RESEARCH, 1993, 10 (03) :317-327
[5]   The stability of cyclodextrin complexes in solution [J].
Connors, KA .
CHEMICAL REVIEWS, 1997, 97 (05) :1325-1357
[6]  
GAO P, 1996, PHARMACEUT RES, V12, P945
[7]   Structural aspects of stereodifferentiation in the solid state [J].
Harata, K .
CHEMICAL REVIEWS, 1998, 98 (05) :1803-1827
[8]   BINDING SPECIFICITY BETWEEN SMALL ORGANIC SOLUTES IN AQUEOUS SOLUTION - CLASSIFICATION OF SOME SOLUTES INTO 2 GROUPS ACCORDING TO BINDING TENDENCIES [J].
HIGUCHI, T ;
KRISTIAN.H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (11) :1601-+
[9]  
Higuchi T., 1965, Interscience, New York, V4, P117
[10]  
HIRAYAMA F, 1987, CYCLODEXTRINS THEIR, P00133